Cargando…
Clinical characteristics, evaluation and outcomes of chylopericardium: a systematic review
OBJECTIVE: Chylopericardium (CPE) is a rare condition associated with accumulation of triglyceride-rich chylous fluid in the pericardial cavity. Due to minimal information on CPE within the literature, we conducted a systematic review of all published CPE cases to understand its clinical characteris...
Autores principales: | , , , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BMJ Publishing Group
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10423526/ https://www.ncbi.nlm.nih.gov/pubmed/36702544 http://dx.doi.org/10.1136/heartjnl-2022-321798 |
_version_ | 1785089472020348928 |
---|---|
author | Verma, Beni Kumar, Ashwin Verma, Nikita Agrawal, Ankit Yesilyaprak, Abdullah Furqan, Muhammad M Mahalwar, Gauranga Berglund, Felix Manna, Sayan Schleicher, Mary Raeisi-Giglou, Pejman Nasser, Mohamed Jabri, Ahmad Wang, Tom Kai Ming Klein, Allan L |
author_facet | Verma, Beni Kumar, Ashwin Verma, Nikita Agrawal, Ankit Yesilyaprak, Abdullah Furqan, Muhammad M Mahalwar, Gauranga Berglund, Felix Manna, Sayan Schleicher, Mary Raeisi-Giglou, Pejman Nasser, Mohamed Jabri, Ahmad Wang, Tom Kai Ming Klein, Allan L |
author_sort | Verma, Beni |
collection | PubMed |
description | OBJECTIVE: Chylopericardium (CPE) is a rare condition associated with accumulation of triglyceride-rich chylous fluid in the pericardial cavity. Due to minimal information on CPE within the literature, we conducted a systematic review of all published CPE cases to understand its clinical characteristics, management and outcomes. METHODS: We performed a literature search and identified cases of patients with CPE from 1946 until May 2021 in accordance with the Preferred Reporting Items for Systematic Reviews and Meta-Analyses guidelines. We identified relevant articles for pooled analyses of clinical, diagnostic and outcome data. RESULTS: A total of 95 articles with 98 patients were identified. Patient demographics demonstrated male predominance (55%), with a mean age of 37±15 years. Time from symptom onset to diagnosis was 5 (Q1 4.5, Q3 14) days, with 74% of patients symptomatic on presentation. Idiopathic CPE (60%) was the most common aetiology. Cardiac tamponade secondary to CPE was seen in 38% of cases. Pericardial fluid analysis was required in 94% of cases. Lymphangiography identified the leakage site in 59% of patients. Medical therapy (total parenteral nutrition, medium-chain triglycerides or octreotide) was undertaken in 63% of cases. In our cohort, 32% progressed towards surgical intervention. During a median follow-up of 180 (Q1 180, Q3 377) days, CPE recurred in 16% of cases. Of the patients with recurrence, 10% were rehospitalised. CONCLUSION: CPE tends to develop in younger patients and may cause serious complications. Many patients fail medical therapy, thereby requiring surgical intervention. Although overall mortality is low, associated morbidities warrant close follow-up and possible reintervention and hospitalisations. |
format | Online Article Text |
id | pubmed-10423526 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | BMJ Publishing Group |
record_format | MEDLINE/PubMed |
spelling | pubmed-104235262023-08-14 Clinical characteristics, evaluation and outcomes of chylopericardium: a systematic review Verma, Beni Kumar, Ashwin Verma, Nikita Agrawal, Ankit Yesilyaprak, Abdullah Furqan, Muhammad M Mahalwar, Gauranga Berglund, Felix Manna, Sayan Schleicher, Mary Raeisi-Giglou, Pejman Nasser, Mohamed Jabri, Ahmad Wang, Tom Kai Ming Klein, Allan L Heart Systematic Review OBJECTIVE: Chylopericardium (CPE) is a rare condition associated with accumulation of triglyceride-rich chylous fluid in the pericardial cavity. Due to minimal information on CPE within the literature, we conducted a systematic review of all published CPE cases to understand its clinical characteristics, management and outcomes. METHODS: We performed a literature search and identified cases of patients with CPE from 1946 until May 2021 in accordance with the Preferred Reporting Items for Systematic Reviews and Meta-Analyses guidelines. We identified relevant articles for pooled analyses of clinical, diagnostic and outcome data. RESULTS: A total of 95 articles with 98 patients were identified. Patient demographics demonstrated male predominance (55%), with a mean age of 37±15 years. Time from symptom onset to diagnosis was 5 (Q1 4.5, Q3 14) days, with 74% of patients symptomatic on presentation. Idiopathic CPE (60%) was the most common aetiology. Cardiac tamponade secondary to CPE was seen in 38% of cases. Pericardial fluid analysis was required in 94% of cases. Lymphangiography identified the leakage site in 59% of patients. Medical therapy (total parenteral nutrition, medium-chain triglycerides or octreotide) was undertaken in 63% of cases. In our cohort, 32% progressed towards surgical intervention. During a median follow-up of 180 (Q1 180, Q3 377) days, CPE recurred in 16% of cases. Of the patients with recurrence, 10% were rehospitalised. CONCLUSION: CPE tends to develop in younger patients and may cause serious complications. Many patients fail medical therapy, thereby requiring surgical intervention. Although overall mortality is low, associated morbidities warrant close follow-up and possible reintervention and hospitalisations. BMJ Publishing Group 2023-09 2023-01-26 /pmc/articles/PMC10423526/ /pubmed/36702544 http://dx.doi.org/10.1136/heartjnl-2022-321798 Text en © Author(s) (or their employer(s)) 2023. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ. https://creativecommons.org/licenses/by-nc/4.0/This is an open access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited, appropriate credit is given, any changes made indicated, and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/ (https://creativecommons.org/licenses/by-nc/4.0/) . |
spellingShingle | Systematic Review Verma, Beni Kumar, Ashwin Verma, Nikita Agrawal, Ankit Yesilyaprak, Abdullah Furqan, Muhammad M Mahalwar, Gauranga Berglund, Felix Manna, Sayan Schleicher, Mary Raeisi-Giglou, Pejman Nasser, Mohamed Jabri, Ahmad Wang, Tom Kai Ming Klein, Allan L Clinical characteristics, evaluation and outcomes of chylopericardium: a systematic review |
title | Clinical characteristics, evaluation and outcomes of chylopericardium: a systematic review |
title_full | Clinical characteristics, evaluation and outcomes of chylopericardium: a systematic review |
title_fullStr | Clinical characteristics, evaluation and outcomes of chylopericardium: a systematic review |
title_full_unstemmed | Clinical characteristics, evaluation and outcomes of chylopericardium: a systematic review |
title_short | Clinical characteristics, evaluation and outcomes of chylopericardium: a systematic review |
title_sort | clinical characteristics, evaluation and outcomes of chylopericardium: a systematic review |
topic | Systematic Review |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10423526/ https://www.ncbi.nlm.nih.gov/pubmed/36702544 http://dx.doi.org/10.1136/heartjnl-2022-321798 |
work_keys_str_mv | AT vermabeni clinicalcharacteristicsevaluationandoutcomesofchylopericardiumasystematicreview AT kumarashwin clinicalcharacteristicsevaluationandoutcomesofchylopericardiumasystematicreview AT vermanikita clinicalcharacteristicsevaluationandoutcomesofchylopericardiumasystematicreview AT agrawalankit clinicalcharacteristicsevaluationandoutcomesofchylopericardiumasystematicreview AT yesilyaprakabdullah clinicalcharacteristicsevaluationandoutcomesofchylopericardiumasystematicreview AT furqanmuhammadm clinicalcharacteristicsevaluationandoutcomesofchylopericardiumasystematicreview AT mahalwargauranga clinicalcharacteristicsevaluationandoutcomesofchylopericardiumasystematicreview AT berglundfelix clinicalcharacteristicsevaluationandoutcomesofchylopericardiumasystematicreview AT mannasayan clinicalcharacteristicsevaluationandoutcomesofchylopericardiumasystematicreview AT schleichermary clinicalcharacteristicsevaluationandoutcomesofchylopericardiumasystematicreview AT raeisigigloupejman clinicalcharacteristicsevaluationandoutcomesofchylopericardiumasystematicreview AT nassermohamed clinicalcharacteristicsevaluationandoutcomesofchylopericardiumasystematicreview AT jabriahmad clinicalcharacteristicsevaluationandoutcomesofchylopericardiumasystematicreview AT wangtomkaiming clinicalcharacteristicsevaluationandoutcomesofchylopericardiumasystematicreview AT kleinallanl clinicalcharacteristicsevaluationandoutcomesofchylopericardiumasystematicreview |